ESHABC: Evaluation of the Effectiveness of Self-hypnosis on Anxiety and Burnout of Nursing Staff

Sponsor
Centre Hospitalier Régional Metz-Thionville (Other)
Overall Status
Recruiting
CT.gov ID
NCT05143203
Collaborator
(none)
66
1
18
3.7

Study Details

Study Description

Brief Summary

Its a prospective, non-interventional, single-center study, involving the human person evaluating the impact of self-hypnosis training on anxiety level and burn out in nursing and medical staff

Condition or Disease Intervention/Treatment Phase
  • Other: Self-hypnosis training

Detailed Description

Like other pandemics, that of Covid-19 had a significant psychological impact on the general population. However, this impact turned out to be even more acute among healthcare workers, in connection with repeated exposure to the risk of infection, the reorganization of care and their specific positioning (...) Psychotraumatic, anxiety and depression symptoms has been observed worldwide. The staff of CHR Metz-Thionville were not spared. From the first wave, the caregivers exposed directly to SARS-CoV-2 (emergency, resuscitation, cohorting sector) requested the hypnosis referent doctor of the structure, in order to benefit from hypnosis sessions in order to better manage their anxiety during the sanitary crisis.

The main demand from caregivers was learning stress management tools and a desire for empowerment without psychological support. For information, the support platform set up by the psychiatry service recorded very few calls (39 caregivers from March 24, 2020 to June 26, 2020). Faced with the influx of hypnotherapy requests, the training unit was asked to set up on-site self-hypnosis training.

It seemed important to measure the effect of this learning on the mental health of caregivers using psychometric scales.

This training was initially offered to front-line caregivers in the fight against the covid-19 pandemic and by extension to all caregivers wishing to be trained in this practice.

It is obvious that this pandemic may have worsened a general ill-being of caregivers already present before the current health crisis.

There are many studies on the management of anxiety and pain in patients with a history of chronic disease, and some have focused specifically on learning self-hypnosis techniques. Even if the protocols for learning self-hypnosis techniques are very heterogeneous in these various pathologies, there is a common observation : "studies show positive results on self-esteem, catastrophism, depression, quality of sleep , the somatizations, the anxiety of the patients (and of their parents for the children), mood ".

To date, and to our knowledge, there are no methodologically rigorous studies measuring the effects of hypnosis or self-hypnosis on the mental health of caregivers.

Publications are often limited to clinical cases or positions related to the use of hypnosis and / or self-hypnosis for the well-being of caregivers.

Study Design

Study Type:
Observational
Anticipated Enrollment :
66 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of the Effectiveness of Self-hypnosis on Anxiety and Burnout of Nursing Staff
Actual Study Start Date :
Oct 12, 2021
Anticipated Primary Completion Date :
Apr 13, 2023
Anticipated Study Completion Date :
Apr 13, 2023

Arms and Interventions

Arm Intervention/Treatment
Staff trained in October 2021

22 nursing staff will follow two days of Self-Hypnosis training in October 2021

Other: Self-hypnosis training
Self-hypnosis training will be conducted in two phases and the evaluation of effectiveness of the training will be measured using GAD7, PHQ9 and PROQOL questionnaires

Staff trained in May 2021

22 nursing staff will follow two days of Self-Hypnosis training in May 2021

Other: Self-hypnosis training
Self-hypnosis training will be conducted in two phases and the evaluation of effectiveness of the training will be measured using GAD7, PHQ9 and PROQOL questionnaires

Control staff without training

22 nursing staff will not follow any training

Outcome Measures

Primary Outcome Measures

  1. Anxiety disorder level evaluation M+6 [6 months after the training of the training of the first group]

    Generalized anxiety disorder screening scale (GAD7) will be measured 6 months after the start of training in self-hypnosis

Secondary Outcome Measures

  1. Anxiety disorder level evaluation D-7 [7 days before the start of the training of the first group]

    Generalized anxiety disorder screening scale (GAD7) The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater.

  2. Anxiety disorder level evaluation M+1 [1 month after the start of the training of the first group]

    Generalized anxiety disorder screening scale (GAD7) The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater.

  3. Anxiety disorder level evaluation M+3 [3 months after the start of the training of the first group]

    Generalized anxiety disorder screening scale (GAD7) The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater.

  4. Anxiety disorder level evaluation M+7 [7 months after the start of the training of the first group]

    Generalized anxiety disorder screening scale (GAD7) The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater.

  5. Anxiety disorder level evaluation M+12 [12 months after the start of the training of the first group]

    Generalized anxiety disorder screening scale (GAD7) The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater.

  6. Anxiety disorder level evaluation M+18 [18 months after the start of the training of the first group]

    Generalized anxiety disorder screening scale (GAD7) The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater.

  7. Depressive disorder evaluation D-7 [7 days before the start of the training of the first group]

    The Patient Health Questionnaire 9-item depression module (PHQ-9) will be used to measure depression disorder of nursing staff 7 days before the start of self-hypnosis training. PHQ-9 is a well-validated, brief, self-reported, diagnostic, and severity measure of depression designed for use in primary care.

  8. Depressive disorder evaluation M+1 [1 month after the start of the training of the first group]

    The Patient Health Questionnaire 9-item depression module (PHQ-9) will be used to measure depression disorder of nursing staff 1 month after the start of self-hypnosis training PHQ-9 is a well-validated, brief, self-reported, diagnostic, and severity measure of depression designed for use in primary care.

  9. Depressive disorder evaluation M+3 [3 months after the start of the training of the first group]

    The Patient Health Questionnaire 9-item depression module (PHQ-9) will be used to measure depression disorder of nursing staff 3 months after the start of self-hypnosis training PHQ-9 is a well-validated, brief, self-reported, diagnostic, and severity measure of depression designed for use in primary care.

  10. Depressive disorder evaluation M+6 [6 months after the start of the training of the first group]

    The Patient Health Questionnaire 9-item depression module (PHQ-9) will be used to measure depression disorder of nursing staff 6 months after the start of self-hypnosis training PHQ-9 is a well-validated, brief, self-reported, diagnostic, and severity measure of depression designed for use in primary care.

  11. Depressive disorder evaluation M+7 [7 months after the start of the training of the first group]

    The Patient Health Questionnaire 9-item depression module (PHQ-9) will be used to measure depression disorder of nursing staff 7 months after the start of self-hypnosis training PHQ-9 is a well-validated, brief, self-reported, diagnostic, and severity measure of depression designed for use in primary care.

  12. Depressive disorder evaluation M+12 [12 months after the start of the training of the first group]

    The Patient Health Questionnaire 9-item depression module (PHQ-9) will be used to measure depression disorder of nursing staff 12 months after the start of self-hypnosis training PHQ-9 is a well-validated, brief, self-reported, diagnostic, and severity measure of depression designed for use in primary care.

  13. Depressive disorder evaluation M+18 [18 months after the start of the training of the first group]

    The Patient Health Questionnaire 9-item depression module (PHQ-9) will be used to measure depression disorder of nursing staff 18 months after the start of self-hypnosis training PHQ-9 is a well-validated, brief, self-reported, diagnostic, and severity measure of depression designed for use in primary care.

  14. Professional Quality of Life evaluation D-7 [7 days before the start of the training of the first group]

    The Professional Quality of Life Scale (ProQOL) is a 30 item self-report questionnaire designed to measure compassion fatigue, work satisfaction and burnout in helping professionals. Helping professionals are defined broadly, from those in health care settings, such as psychologists, nurses and doctors. It is useful for workers who perform emotional labour as well as professionals who are exposed to traumatic situations. Raw scores between 10 and 50 are presented for the three subscales (1) Compassion Satisfaction, (2) Burnout and (3) Secondary Traumatic Stress. Each score is also presented as a percentile rank comparing the respondent's scores to scores of helping professionals generally (such as psychologists, doctors, teachers and first responders). A percentile of 50 represents an average score. High scores on Compassion Satisfaction and low scores on Burnout and Secondary Traumatic Stress are indicative of professional health.

  15. Professional Quality of Life evaluation M+6 [6 Months after the start of the training of the first group]

    The Professional Quality of Life Scale (ProQOL) is a 30 item self-report questionnaire designed to measure compassion fatigue, work satisfaction and burnout in helping professionals. Helping professionals are defined broadly, from those in health care settings, such as psychologists, nurses and doctors. It is useful for workers who perform emotional labour as well as professionals who are exposed to traumatic situations. Raw scores between 10 and 50 are presented for the three subscales (1) Compassion Satisfaction, (2) Burnout and (3) Secondary Traumatic Stress. Each score is also presented as a percentile rank comparing the respondent's scores to scores of helping professionals generally (such as psychologists, doctors, teachers and first responders). A percentile of 50 represents an average score. High scores on Compassion Satisfaction and low scores on Burnout and Secondary Traumatic Stress are indicative of professional health.

  16. Professional Quality of Life evaluation M+12 [12 Months after the start of the training of the first group]

    The Professional Quality of Life Scale (ProQOL) is a 30 item self-report questionnaire designed to measure compassion fatigue, work satisfaction and burnout in helping professionals. Helping professionals are defined broadly, from those in health care settings, such as psychologists, nurses and doctors. It is useful for workers who perform emotional labour as well as professionals who are exposed to traumatic situations. Raw scores between 10 and 50 are presented for the three subscales (1) Compassion Satisfaction, (2) Burnout and (3) Secondary Traumatic Stress. Each score is also presented as a percentile rank comparing the respondent's scores to scores of helping professionals generally (such as psychologists, doctors, teachers and first responders). A percentile of 50 represents an average score. High scores on Compassion Satisfaction and low scores on Burnout and Secondary Traumatic Stress are indicative of professional health.

  17. Professional Quality of Life evaluation M+18 [18 Months after the start of the training of the first group]

    The Professional Quality of Life Scale (ProQOL) is a 30 item self-report questionnaire designed to measure compassion fatigue, work satisfaction and burnout in helping professionals. Helping professionals are defined broadly, from those in health care settings, such as psychologists, nurses and doctors. It is useful for workers who perform emotional labour as well as professionals who are exposed to traumatic situations. Raw scores between 10 and 50 are presented for the three subscales (1) Compassion Satisfaction, (2) Burnout and (3) Secondary Traumatic Stress. Each score is also presented as a percentile rank comparing the respondent's scores to scores of helping professionals generally (such as psychologists, doctors, teachers and first responders). A percentile of 50 represents an average score. High scores on Compassion Satisfaction and low scores on Burnout and Secondary Traumatic Stress are indicative of professional health.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Nursing staff of the CHR Metz-Thionville: doctors, nurses or nursing assistants

  • Over 18 years old

  • Not objecting to participating in the study

  • Affiliated to a social security scheme

Exclusion Criteria:

Hospital staff

  • Not speaking and/or not understanding the French language.

  • Having disorders of higher functions.

  • With known history of schizophrenia.

  • Deaf or hard of hearing.

  • already trained in hypnosis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Régional Metz-Thionville Metz Grand-Est France 57085

Sponsors and Collaborators

  • Centre Hospitalier Régional Metz-Thionville

Investigators

  • Principal Investigator: Nazmine GULER, MD, CHR Metz Thionville Hopital de Mercy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Régional Metz-Thionville
ClinicalTrials.gov Identifier:
NCT05143203
Other Study ID Numbers:
  • 2021-04Obs-CHRMT
First Posted:
Dec 3, 2021
Last Update Posted:
Dec 3, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 3, 2021